Search Results - "Feldman, Howard H."

evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease

Cummings, Jeffrey L., Atri, Alireza, Feldman, Howard H., Hansson, Oskar, Sano, Mary, Knop, Filip K., Johannsen, Peter, León, Teresa, Scheltens, Philip

Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Clinical Memory Research, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Klinisk minnesforskning, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), MultiPark: Multidisciplinary research focused on Parkinson´s disease, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), MultiPark: Multidisciplinary research focused on Parkinson´s disease, Originator, Lund University, Profile areas and other strong research environments, Lund University Profile areas, LU Profile Area: Proactive Ageing, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Lunds universitets profilområden, LU profilområde: Proaktivt åldrande, Originator

A framework for translating tauopathy therapeutics: Drug discovery to clinical trials

Feldman, Howard H, Cummings, Jeffrey L, Boxer, Adam L, Staffaroni, Adam M, Knopman, David S, Rizzo, Stacey J Sukoff, Territo, Paul R, Arnold, Steven E, Ballard, Clive, Beher, Dirk, Boeve, Bradley F, Dacks, Penny A, Diaz, Kristophe, Ewen, Colin, Fiske, Brian, Gonzalez, M Isabel, Harris, Glenn A, Hoffman, Beth J, Martinez, Terina N, McDade, Eric, Nisenbaum, Laura K, Palma, Jose‐Alberto, Quintana, Melanie, Rabinovici, Gil D, Rohrer, Jonathan D, Rosen, Howard J, Troyer, Matthew D, Kim, Doo Yeon, Tanzi, Rudolph E, Zetterberg, Henrik, Ziogas, Nick K, May, Patrick C, Rommel, Amy

application/pdf

Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer’s disease, positive for plasma p-tau217

Kovacech, Branislav, Cullen, Nicholas C., Novak, Petr, Hanes, Jozef, Kontsekova, Eva, Katina, Stanislav, Parrak, Vojtech, Fresser, Michal, Vanbrabant, Jeroen, Feldman, Howard H., Winblad, Bengt, Stoops, Erik, Vanmechelen, Eugeen, Zilka, Norbert

Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), MultiPark: Multidisciplinary research focused on Parkinson´s disease, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), MultiPark: Multidisciplinary research focused on Parkinson´s disease, Originator, Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Clinical Memory Research, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Klinisk minnesforskning, Originator

Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the “ADAMANT” randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial

Cullen, Nicholas C., Novak, Petr, Tosun, Duygu, Kovacech, Branislav, Hanes, Jozef, Kontsekova, Eva, Fresser, Michal, Ropele, Stefan, Feldman, Howard H., Schmidt, Reinhold, Winblad, Bengt, Zilka, Norbert

Lund University, Faculty of Medicine, Department of Clinical Sciences, Malmö, Clinical Memory Research, Lunds universitet, Medicinska fakulteten, Institutionen för kliniska vetenskaper, Malmö, Klinisk minnesforskning, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), MultiPark: Multidisciplinary research focused on Parkinson´s disease, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), MultiPark: Multidisciplinary research focused on Parkinson´s disease, Originator

Asian Cohort for Alzheimer's Disease (ACAD) pilot study on genetic and non‐genetic risk factors for Alzheimer's disease among Asian Americans and Canadians

Ho, Pei‐Chuan, Yu, Wai Haung, Tee, Boon Lead, Lee, Wan‐Ping, Li, Clara, Gu, Yian, Yokoyama, Jennifer S, Reyes‐Dumeyer, Dolly, Choi, Yun‐Beom, Yang, Hyun‐Sik, Vardarajan, Badri N, Tzuang, Marian, Lieu, Kevin, Lu, Anna, Faber, Kelley M, Potter, Zoë D, Revta, Carolyn, Kirsch, Maureen, McCallum, Jake, Mei, Diana, Booth, Briana, Cantwell, Laura B, Chen, Fangcong, Chou, Sephera, Clark, Dewi, Deng, Michelle, Hong, Ting Hei, Hwang, Ling‐Jen, Jiang, Lilly, Joo, Yoonmee, Kang, Younhee, Kim, Ellen S, Kim, Hoowon, Kim, Kyungmin, Kuzma, Amanda B, Lam, Eleanor, Lanata, Serggio C, Lee, Kunho, Li, Donghe, Li, Mingyao, Li, Xiang, Liu, Chia‐Lun, Liu, Collin, Liu, Linghsi, Lupo, Jody‐Lynn, Nguyen, Khai, Pfleuger, Shannon E, Qian, James, Qian, Winnie, Ramirez, Veronica, Russ, Kristen A, Seo, Eun Hyun, Song, Yeunjoo E, Tartaglia, Maria Carmela, Tian, Lu, Torres, Mina, Vo, Namkhue, Wong, Ellen C, Xie, Yuan, Yau, Eugene B, Yi, Isabelle, Yu, Victoria, Zeng, Xiaoyi, St George‐Hyslop, Peter, Au, Rhoda, Schellenberg, Gerard D, Dage, Jeffrey L, Varma, Rohit, Hsiung, Ging‐Yuek R, Rosen, Howard, Henderson, Victor W, Foroud, Tatiana, Kukull, Walter A, Peavy, Guerry M, Lee, Haeok, Feldman, Howard H, Mayeux, Richard, Chui, Helena, Jun, Gyungah R, Park, Van M Ta, Chow, Tiffany W, Wang, Li‐San

Developing the Healthy Actions and Lifestyles to Avoid Dementia or Hispanos y el ALTo a la Demencia program

Moukarzel, Sara, Zlatar, Zvinka Z, Hartman, Sheri J, Lomas, Derek, Feldman, Howard H, Banks, Sarah J, Group, HALT‐AD Study

A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with early Alzheimer’s Disease

Galasko, Douglas^{Aff1, IDs1319502401490z_cor1}, Farlow, Martin R., Lucey, Brendan P., Honig, Lawrence S., Elbert, Donald, Bateman, Randall, Momper, Jeremiah, Thomas, Ronald G., Rissman, Robert A., Pa, Judy, Aslanyan, Vahan, Balasubramanian, Archana, West, Tim, Maccecchini, Maria, Feldman, Howard H.

Tailoring implementation strategies for the healthy actions and lifestyles to Avoid Dementia or Hispanos y el ALTo a la Demencia Program: Lessons learned from a survey study

Moukarzel, Sara ^{a, b}, Araujo-Menendez, Carlos E.E. ^c, Galang, Eliza ^b, Zlatar, Zvinka Z. ^d, Feldman, Howard H. ^{a, b}, Banks, Sarah J. ^{a, d, ⁎}

Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research

Smith, Eric E. ^{a, ⁎}, Phillips, Natalie A. ^b, Feldman, Howard H. ^c, Borrie, Michael ^d, Ganesh, Aravind ^a, Henri-Bhargava, Alexandre ^e, Desmarais, Philippe ^f, Frank, Andrew ^g, Badhwar, AmanPreet ^h, Barlow, Laura ⁱ, Bartha, Robert ^d, Best, Sarah ^d, Bethell, Jennifer ^j, Bhangu, Jaspreet ^d, Black, Sandra E. ^k, Bocti, Christian ^l, Bronskill, Susan E. ^m, Burhan, Amer M. ⁿ, Calon, Frederic ^o, Camicioli, Richard ^p, Campbell, Barry ^q, Collins, D. Louis ^r, Dadar, Mahsa ^r, DeMarco, Mari L. ^s, Ducharme, Simon ^t, Duchesne, Simon ^u, Einstein, Gillian ^v, Fisk, John D. ^w, Gawryluk, Jodie R. ^x, Grossman, Linda ^z, Ismail, Zahinoor ^a, Itzhak, Inbal ^y, Joshi, Manish ^a, Harrison, Arthur ^z, Kröger, Edeltraut ^aa, Kumar, Sanjeev ^v, Laforce, Robert ^u, Lanctot, Krista L. ^ab, Lau, Meghan ^z, Lee, Linda ^ac, Masellis, Mario ^ad, Massoud, Fadi ^ae, Mitchell, Sara B. ^v, Montero-Odasso, Manuel ^aj, Myers Barnett, Karen ^z, Nygaard, Haakon B. ⁱ, Pasternak, Stephen H. ^af, Peters, Jody ^z, Rajah, M. Natasha ^ag, Robillard, Julie M. ⁱ, Rockwood, Ken ^w, Rosa-Neto, Pedro ^r, Seitz, Dallas P. ^a, Soucy, Jean-Paul ^r, Trenaman, Shanna C. ^ah, Wellington, Cheryl L. ^ak, Zadem, Aicha ^l, Chertkow, Howard ^ai

Brain health PRO/Santé cerveau PRO: The development of a web-based program for dementia literacy and risk factor reduction

Belleville, Sylvie ^{a, b, ⁎}, Anderson, Nicole D. ^{c, d}, Bherer, Louis ^{a, e, f}, Camicioli, Richard ^{g, h}, Carrier, Julie ^{b, i}, Chan, Senny ^d, Cuesta, Marc ^a, Dang-Vu, Thien Thanh ^{a, j}, Dwosh, Emily ^{k, l}, Fiocco, Alexandra J. ^m, Ferland, Guylaine ^{f, n}, Gilbert, Brigitte ^o, Harris, Elaine ^p, Itzhak, Inbal ^q, Jarrett, Pamela ^{r, s}, Kadri, Mohamed Abdelhafid ^a, Laurin, Danielle ^t, Liu-Ambrose, Teresa ^{u, v, w}, McGibbon, Chris A. ^x, Middleton, Laura ^y, Miller, Lesley ^p, Nygaard, Haakon B. ^{k, l}, Montero-Odasso, Manuel ^{z, aa, bb}, Murphy, Kelly ^d, Phillips, Natalie ^cc, Pichora-Fuller, M. Kathleen ^d, Robillard, Julie M. ^k, Smith, Eric E. ^{dd, ee}, Speechley, Mark ^kk, Trigui, Amal ^{a, n}, Wittich, Walter ^ff, Chertkow, Howard ^{c, q, gg, hh}, Feldman, Howard H. ^{ii, jj}

Challenges and Opportunities for Consideration of Efavirenz Drug Repurposing for Alzheimer’s Disease Therapeutics

Boyarko, Ben^{aff1, aff2}, Podvin, Sonia^aff1, Greenberg, Barry^aff3, Arnold, Steven^aff4, Juanes, Almudena Maroto^aff5, van der Kant, Rik^aff5, Goldstein, Lawrence^aff6, Momper, Jeremiah D.^aff1, Bang, Anne^aff7, Silverman, James^{aff2, aff8}, Feldman, Howard H.^{aff2, aff8}, Hook, Vivian^{aff1, aff2, aff8}

Optimal Weighting of Preclinical Alzheimer’s Cognitive Composite (PACC) Scales to Improve their Performance as Outcome Measures for Alzheimer’s Disease Clinical Trials

Wang, Xinran, Jacobs, Diane, Salmon, David P, Feldman, Howard H, Edland, Steven D

application/pdf

Exploring Social Cognition Tests to Differentiate Frontotemporal Dementia from Depression

Lichtenstein, Maya L, Stewart, Peter V, Kirchner, H Lester, Finney, Glen, Feldman, Howard H

application/pdf

Multidomain trials to prevent dementia: addressing methodological challenges

Montero-Odasso, Manuel, Zou, GY, Kamkar, Nellie, Feldman, Howard H, Belleville, Sylvie, Chertkow, Howard, Nygaard, Haakon B, Son, Surim, Speechley, Mark

application/pdf

Committee on High‐quality Alzheimer's Disease Studies (CHADS) consensus report

Jicha, Greg A, Abner, Erin L, Arnold, Steven E, Carrillo, Maria C, Dodge, Hiroko H, Edland, Steven D, Fargo, Keith N, Feldman, Howard H, Goldstein, Larry B, Hendrix, James, Peters, Ruth, Robillard, Julie M, Schneider, Lon S, Titiner, Jodi R, Weber, Christopher J, Research and Treatment, the Clinical Trial Advancement Methodology Professional Interest Area of the International Society to Advance Alzheimer's

Current directions in tau research: Highlights from Tau 2020

Sexton, Claire, Snyder, Heather, Beher, Dirk, Boxer, Adam L, Brannelly, Pat, Brion, Jean‐Pierre, Buée, Luc, Cacace, Angela M, Chételat, Gaël, Citron, Martin, DeVos, Sarah L, Diaz, Kristophe, Feldman, Howard H, Frost, Bess, Goate, Alison M, Gold, Michael, Hyman, Bradley, Johnson, Keith, Karch, Celeste M, Kerwin, Diana R, Koroshetz, Walter J, Litvan, Irene, Morris, Huw R, Mummery, Catherine J, Mutamba, James, Patterson, Marc C, Quiroz, Yakeel T, Rabinovici, Gil D, Rommel, Amy, Shulman, Melanie B, Toledo‐Sherman, Leticia M, Weninger, Stacie, Wildsmith, Kristin R, Worley, Susan L, Carrillo, Maria C

Protocol for the Brain Health Support Program Study of the Canadian Therapeutic Platform Trial for Multidomain Interventions to Prevent Dementia (CAN-THUMBS UP): A Prospective 12-Month Intervention Study

Feldman, Howard H.^{Aff1, Aff2, IDjpad202365_cor1}, Belleville, S.^{Aff3, Aff4}, Nygaard, H. B., Montero-Odasso, M.^{Aff6, Aff7}, Durant, J.^{Aff1, Aff2}, Lupo, J.-L.^{Aff1, Aff2}, Revta, C.^{Aff1, Aff2}, Chan, S., Cuesta, M., Slack, P. J., Winer, S., Brewster, P. W. H., Hofer, S. M., Lim, A., Centen, A., Jacobs, D. M.^{Aff1, Aff2}, Anderson, N. D., Walker, J. D., Speechley, M. R., Zou, G. Y., Chertkow, H.

Pharmacological thiamine levels as a therapeutic approach in Alzheimer's disease

Gibson, Gary E, Feldman, Howard H, Zhang, Sheng, Flowers, Sarah A, Luchsinger, José A

application/pdf

Home EEG sleep assessment shows reduced slow‐wave sleep in mild–moderate Alzheimer's disease

Kent, Brianne A, Casciola, Amelia A, Carlucci, Sebastiano K, Chen, Meghan, Stager, Sam, Mirian, Maryam S, Slack, Penelope, Valerio, Jason, McKeown, Martin J, Feldman, Howard H, Nygaard, Haakon B

application/pdf

T2 Protect AD: Achieving a rapid recruitment timeline in a multisite clinical trial for individuals with mild to moderate Alzheimer's disease

Shadyab, Aladdin H, LaCroix, Andrea Z, Matthews, Genevieve, Bennett, Daniel, Shadyab, Alexandre A, Tan, Donna, Thomas, Ronald G, Mason, Jennifer, Lopez, Alex, Askew, Brianna, Donahue, Lia, Kaplita, Stephen, Qureshi, Irfan A, Huisa, Branko, Feldman, Howard H, Group, for the Alzheimer's Disease Cooperative Study T2 Protect AD Study

application/pdf